vimarsana.com

Page 139 - மருத்துவ ரீதியாக ஒருங்கிணைந்த வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Virtual presentation about Medicare set for June 8 for Central Coast seniors, caregivers

Virtual presentation about Medicare set for June 8 for Central Coast seniors, caregivers
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

What To Do When You Notice Your Aging Parents Are Starting To Slip

What To Do When You Notice Your Aging Parents Are Starting To Slip
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Welcome To IANS Live - BUSINESS - Samsung, Sony, Hitachi invest in UK healthtech firm Huma

Photo Credit: IANS IANSLive London, May 12 (IANS) Samsung, Sony and Hitachi have invested in UK heathtech company Huma Therapeutics Limited in its latest Series C funding round with financing of approximately $130 million, the company said on Wednesday. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 12-May-2021

Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 [ ]

12 maggio 2021 16:52 Fonte: Adnkronos #salute-e-benessere Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Results, when availa

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.